Currently, there are limited therapeutic strategies for ALS patients, but alternative approaches such as antisense oligonucleotides (ASOs) treatments are emerging as a viable treatment in SOD1-ALS cases. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.